Project Grant F32DA061553
Award Date
1/1/25
Completion Date
8/31/26
Dollars Obligated
$164K
Federal Agency
National Institute on Drug Abuse
Awardee
Brown University (E3FDXZ6TBHW3)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
The National Institute on Drug Abuse awarded Brown University a $2,838,472 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a prospective mixed-methods investigation on factors associated with cannabis use trajectories among young adults aged 18-25. The research will use a behavioral economic framework to examine how micro-transitions and critical life events during young adulthood influence changes in cannabis use patterns, with a focus on factors such...
The National Institute on Drug Abuse (NIDA) awarded a $656,121 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Johns Hopkins University to conduct research on the effects of adolescent cannabis use on prefrontal cortex maturation and cognitive function. The 5-year project aims to investigate how cannabis exposure during adolescence affects microglia-mediated changes in the prefrontal cortex that lead to impaired inhibitory control and executive functions....
This $376,078 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the relationship between cannabis use for coping purposes and cannabis use quantity and frequency. The key objectives are to: 1) Experimentally test if cannabis use increases after stress induction among individuals who use cannabis for coping, 2) Examine if social anxiety and inhibitory control moderate the...
This R01 project grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to assess the neurobehavioral impacts of medical cannabis use in a sample of 120 patients in Minnesota, as compared to 60 non-cannabis using controls. The $663,150 award, with a project period from September 30, 2024, to May 31, 2029, will fund a comprehensive pre-post assessment of cognition, neural function, and substance use disorder risk in...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $233,250 study examining the relationship between early cannabis use (ECAN) and opioid use disorder (OUD). The key objectives are to: Assess the association between ECAN and both proximal (e.g., initial opioid responses) and distal (e.g., OUD severity) aspects of opioid involvement, including whether these associations are modified by...
The National Institute on Drug Abuse (NIDA) awarded a $166,512 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Trustees of Columbia University in the City of New York, to be completed by July 31, 2029. The grant will support a longitudinal study examining cognitive, behavioral, and brain-based markers of self-regulation as predictors of cannabis and alcohol co-use in adolescence. The study aims to investigate how impairments in executive function and high...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $568,855 to The Medical University of South Carolina (MUSC) from May 1, 2024 to April 30, 2026. The project aims to identify the neurobiological mechanisms underlying changes in PTSD-like symptoms after cannabis use. The research will characterize cell-specific neuroadaptations in the nucleus accumbens core and ventral pallidum in response to...
This federal Project Grant award of $713,908 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study investigating the neural and psychiatric consequences of cannabis use in adolescents with depression. The study aims to prospectively examine the effects of cannabis, the most commonly used illicit drug among teenagers, on reward and pain neurocircuits in this population. The research seeks to understand how...
This $844,946 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to investigate the epigenetic regulation of inflammasome activation and its modulation by cannabinoids during chronic SIV infection and cocaine use. Specifically, the research will: Examine the epigenetic mechanisms underlying cannabinoid-mediated reduction of cocaine-induced inflammasome activation in blood monocytes, brain, and...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on investigating the co-use of cannabis and prescription opioids among emerging adults in medical settings. The $1,362,860 award, with an effective date of September 15, 2024 and an ultimate completion date of May 31, 2029, will support a prospective cohort study to examine the short- and long-term trajectories of opioid and...